한글목차

보조생식기술(ART)의 동향과 전망

세계 보조생식기술(ART) 시장 규모는 2024-2030년 연평균 9.6% 성장하여 2030년까지 약 462억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 불임률 증가, 보조생식기술(ART) 기술의 급속한 기술 발전, 불임 치료에 대한 인식이 높아지는 것입니다. 세계 보조생식기술(ART) 시장의 미래는 불임 클리닉, 병원, 수술센터, 임상 연구 기관 등 다양한 시장에서의 기회로 인해 유망합니다.

보조생식기술(ART) 시장 인사이트

Lucintel의 예측에 따르면, 불임률 감소, 좌식 생활습관 증가, 임신 지연외수 경향 증가, 체외수정 비용이 낮아짐에 따라 체정은 예측 기간 동안 더 큰 부문을 차지할 것으로 보입니다.

이 시장에서 불임 클리닉은 생식 관련 사례 증가, 건강에 해로운 생활습관 증가, 불임 클리닉 증가로 인해 불임 클리닉이 가장 큰 부문으로 남을 것으로 보입니다.

유럽은 불임 유병률 증가, 가처분 소득 증가, 체외수정(IVF)에 대한 정부 및 민간단체의 자금 지원 증가, 이 지역의 불임 기술 발전으로 인해 예측 기간 동안 가장 높은 성장률을 보일 것으로 예상됩니다.

시장 규모 및 추정치 : 보조생식기술(ART)기술 시장 규모를 금액(10억 달러)으로 추산

동향 및 예측 분석 : 각 부문 및 지역별 시장 동향(2018-2023년) 및 예측(2024-2030년)

세분화 분석 : 제품별, 기술별, 최종 이용 산업별, 지역별 등 다양한 부문별로 보조생식기술(ART) 시장을 금액(미화 10억 달러)으로 추정

지역별 분석 : 북미, 유럽, 아시아태평양 및 기타 지역으로 나누어 보조생식기술(ART) 시장을 분석합니다.

성장 기회 : 보조생식기술(ART) 시장의 제품, 기술, 최종 사용 산업 및 지역별 성장 기회 분석

전략 분석 : 보조생식기술(ART) 시장의 M&A, 신제품 개발, 경쟁 구도 등

Porter's Five Forces 모델을 기반으로 한 산업 경쟁 강도 분석

이 보고서는 다음과 같은 11가지 주요 질문에 대한 답변을 담고 있습니다.

• Q.1. 시장 부문 중 가장 유망하고 성장성이 높은 기회는 무엇인가?
• Q.2. 어떤 부문이 더 빠른 속도로 성장할 것이며, 그 이유는 무엇인가?
• Q.3. 향후 성장이 가속화될 것으로 예상되는 지역과 그 이유는?
• Q.4. 시장 역학에 영향을 미치는 주요 요인은? 시장의 주요 과제와 비즈니스 리스크는 무엇인가?
• Q.5. 이 시장에서의 비즈니스 리스크와 경쟁 위협은 무엇인가?
• Q.6. 이 시장의 새로운 트렌드와 그 이유는?
• Q.7. 시장에서의 고객 수요 변화에는 어떤 것들이 있는가?
• Q.8. 이 시장의 새로운 발전과 그 발전을 주도하고 있는 기업은?
• Q.9. 이 시장의 주요 기업은? 주요 기업들은 사업 성장을 위해 어떤 전략적 노력을 기울이고 있는가?
• Q.10. 이 시장의 경쟁 제품에는 어떤 것들이 있으며, 소재 및 제품 대체에 따른 시장 점유율 하락의 위협은 어느 정도인가?
• Q.11. 지난 5년간 어떤 M&A가 이루어졌고, 업계에 어떤 영향을 미쳤는가?

목차

제1장 주요 요약

제2장 세계의 보조생식기술(ART) 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 촉진요인과 과제

제3장 시장 동향과 예측 분석 : 2018-2030년

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 보조생식기술(ART) 시장 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 보조생식기술(ART) 시장 : 제품별
  • Instrument
  • Accessory & Disposable
  • Reagents & Media
• 세계의 보조생식기술(ART) 시장 : 기술별
  • 체외수정
  • 인공수정
  • 기타
• 세계의 보조생식기술(ART) 시장 : 최종 이용 산업별
  • 불임 치료 클리닉
  • 병원
  • 외과 센터
  • 임상 연구
  • 기타

제4장 시장 동향과 예측 분석 : 지역별(2018-2030년)

• 세계의 보조생식기술(ART) 시장 : 지역별
• 북미의 보조생식기술 시장
• 유럽의 보조생식기술 시장
• 아시아태평양의 보조생식기술 시장
• 기타 지역의 보조생식기술 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter의 Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 제품별 세계의 보조생식기술(ART) 시장 성장 기회
  • 기술별 세계의 보조생식기술(ART) 시장 성장 기회
  • 최종 이용 산업별 세계의 보조생식기술(ART) 시장 성장 기회
  • 지역별 세계의 보조생식기술(ART) 시장 성장 기회
• 세계 보조생식기술 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 보조생식기술(ART) 시장 능력 확대
  • 세계 보조생식기술 시장의 인수합병(M&A) 및 합작투자(JV)
  • 인증 및 라이선싱

제7장 유력 기업의 기업 개요

• Cosmos Biomedical
• Microm U.K.
• CooperSurgical
• FUJIFILM Irvine Scientific
• Cryolab
• Vitrolife AB
• European Sperm Bank
• Bloom IVF Centre
• Merck
• Ferring B.V.

영문목차

Assisted Reproductive Technology Trends and Forecast

The future of the global assisted reproductive technology market looks promising with opportunities in the fertility clinic, hospital, surgical center, and clinical research institute markets. The global assisted reproductive technology market is expected to reach an estimated $46.2 billion by 2030 with a CAGR of 9.6% from 2024 to 2030. The major drivers for this market are rising prevalence of infertility rate, rapid technological advancements in assisted reproductive technology, and and growing awareness regarding infertility treatment.

A more than 150-page report is developed to help in your business decisions.

Assisted Reproductive Technology by Segment

The study includes a forecast for the global assisted reproductive technology by product, technology, end use industry, and region.

Assisted Reproductive Technology Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Instrument
• Accessory & Disposable
• Reagents & Media

Assisted Reproductive Technology Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• In Vitro-Fertilization
• Artificial Insemination
• Others

Assisted Reproductive Technology Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

• Fertility Clinic
• Hospital
• Surgical Center
• Clinical Research Institute
• Others

Assisted Reproductive Technology Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Assisted Reproductive Technology Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies assisted reproductive technology companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the assisted reproductive technology companies profiled in this report include-

• Cosmos Biomedical
• Microm U.K.
• Coopersurgical
• Fujifilm Irvine Scientific
• Cryolab
• Vitrolife Ab
• European Sperm Bank
• Bloom Ivf Centre
• Merck
• Ferring B.V.

Assisted Reproductive Technology Market Insights

Lucintel forecasts that in vitro-fertilization will remain the larger segment over the forecast period due to reducing fertility rate, growing sedentary lifestyle, growing trend of delayed pregnancy and low cost of IVF procedure.

Within this market, fertility clinic will remain the largest segment due to growing prevalence of reproductive cases, rising unhealthy lifestyle, and increase in the number of fertility clinics.

Europe is expected to witness highest growth over the forecast period due to growing prevalence of infertility, increasing disposable incomes, and rising funds from government and private organization for in-vitro fertilization (IVF), and advancements in technology for infertility in the region.

Features of the Global Assisted Reproductive Technology Market

Market Size Estimates: Assisted reproductive technology market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Assisted reproductive technology market by various segments, such as by product, technology, end use industry and region in terms of($B).

Regional Analysis: Assisted reproductive technology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, technologies, end use industries, and regions for the assisted reproductive technology market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the assisted reproductive technology market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the assisted reproductive technology market size?

Answer: The global assisted reproductive technology market is expected to reach an estimated $46.2 billion by 2030.

Q.2 What is the growth forecast for assisted reproductive technology market?

Answer: The global assisted reproductive technology market is expected to grow with a CAGR of 9.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the assisted reproductive technology market?

Answer: The major drivers for this market are rising prevalence of infertility rate, rapid technological advancements in assisted reproductive technology, and and growing awareness regarding infertility treatment.

Q4. What are the major segments for assisted reproductive technology market?

Answer: The future of the assisted reproductive technology market looks promising with opportunities in the fertility clinic, hospital, surgical center, and clinical research institute markets.

Q5. Who are the key assisted reproductive technology market companies?

Answer: Some of the key assisted reproductive technology companies are as follows:

• Cosmos Biomedical
• Microm U.K.
• CooperSurgical
• FUJIFILM Irvine Scientific
• Cryolab
• Vitrolife AB
• European Sperm Bank
• Bloom IVF Centre
• Merck
• Ferring B.V.

Q6. Which assisted reproductive technology market segment will be the largest in future?

Answer: Lucintel forecasts that in vitro-fertilization will remain the larger segment over the forecast period due to reducing fertility rate, growing sedentary lifestyle, growing trend of delayed pregnancy and low cost of IVF procedure.

Q7. In assisted reproductive technology market, which region is expected to be the largest in next 5 years?

Answer: Europe is expected to witness highest growth over the forecast period due to growing prevalence of infertility, increasing disposable incomes, and rising funds from government and private organization for in-vitro fertilization (IVF), and advancements in technology for infertility in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the assisted reproductive technology market by product (instrument, accessory & disposable, and reagents & media), technology (in vitro-fertilization, artificial insemination, and others), end use industry (fertility clinic, hospital, surgical center, clinical research institute, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Assisted Reproductive Technology Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Assisted Reproductive Technology Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Assisted Reproductive Technology Market by Product
  • 3.3.1: Instrument
  • 3.3.2: Accessory & Disposable
  • 3.3.3: Reagents & Media
• 3.4: Global Assisted Reproductive Technology Market by Technology
  • 3.4.1: In Vitro-Fertilization
  • 3.4.2: Artificial Insemination
  • 3.4.3: Others
• 3.5: Global Assisted Reproductive Technology Market by End Use Industry
  • 3.5.1: Fertility Clinic
  • 3.5.2: Hospital
  • 3.5.3: Surgical Center
  • 3.5.4: Clinical Research Institute
  • 3.5.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Assisted Reproductive Technology Market by Region
• 4.2: North American Assisted Reproductive Technology Market
  • 4.2.2: North American Assisted Reproductive Technology Market by End Use Industry: Fertility Clinic, Hospital, Surgical Center, Clinical Research Institute, and Others
• 4.3: European Assisted Reproductive Technology Market
  • 4.3.1: European Assisted Reproductive Technology Market by Technology: In Vitro-Fertilization, Artificial Insemination, and Others
  • 4.3.2: European Assisted Reproductive Technology Market by End Use Industry: Fertility Clinic, Hospital, Surgical Center, Clinical Research Institute, and Others
• 4.4: APAC Assisted Reproductive Technology Market
  • 4.4.1: APAC Assisted Reproductive Technology Market by Technology: In Vitro-Fertilization, Artificial Insemination, and Others
  • 4.4.2: APAC Assisted Reproductive Technology Market by End Use Industry: Fertility Clinic, Hospital, Surgical Center, Clinical Research Institute, and Others
• 4.5: ROW Assisted Reproductive Technology Market
  • 4.5.1: ROW Assisted Reproductive Technology Market by Technology: In Vitro-Fertilization, Artificial Insemination, and Others
  • 4.5.2: ROW Assisted Reproductive Technology Market by End Use Industry: Fertility Clinic, Hospital, Surgical Center, Clinical Research Institute, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Assisted Reproductive Technology Market by Product
  • 6.1.2: Growth Opportunities for the Global Assisted Reproductive Technology Market by Technology
  • 6.1.3: Growth Opportunities for the Global Assisted Reproductive Technology Market by End Use Industry
  • 6.1.4: Growth Opportunities for the Global Assisted Reproductive Technology Market by Region
• 6.2: Emerging Trends in the Global Assisted Reproductive Technology Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Assisted Reproductive Technology Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Assisted Reproductive Technology Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Cosmos Biomedical
• 7.2: Microm U.K.
• 7.3: CooperSurgical
• 7.4: FUJIFILM Irvine Scientific
• 7.5: Cryolab
• 7.6: Vitrolife AB
• 7.7: European Sperm Bank
• 7.8: Bloom IVF Centre
• 7.9: Merck
• 7.10: Ferring B.V.